Skip to content
Disclosery

Northpond Ventures, LLC

Follow

13F filer, CIK 1911245, Bethesda, MD

Northpond Ventures, LLC reported $184,349,014 across 5 holdings for the quarter ended 2022-12-31, in a 13F-HR filed 2023-02-01.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-23-009328

Period
2022-12-31
Reported value
$184M
Holdings
5
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q4 2022

Share positions as resolved from 13F-HR 0001104659-23-009328, largest first. % of portfolio is the value over $184,349,014, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
DICE THERAPEUTICS INCDICE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 3,292,871 shares 3,292,871$103M55.73%0
VIGIL NEUROSCIENCE INCVIGIL NEUROSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 4,214,498 shares 4,214,498$52.7M28.58%0
ISOPLEXIS CORPISOPLEXIS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 8,808,531 shares 8,808,531$13.7M7.41%0
CODEX DNA INCCODEX DNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 9,844,130 shares 9,844,130$11.8M6.41%0
CADLCANDEL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 1,935,215 shares 1,935,215$3.46M1.88%0Timeline

How Q4 2022 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-23-009328 base2023-02-01acceptance time not in the bulk data set